Orgentec Diagnostika Takes Up Residence on Water Street
May 16, 2014
Water Street Healthcare Partners has committed equity for a majority position in Orgentec Diagnostika, as well as for future acquisitions to help build the company. Specializing in diagnostic assays for autoimmune and infectious diseases, Orgentec offers a portfolio of more than 300 tests, primarily enzyme-linked immunosorbent assays, which help diagnose various disorders and diseases. Water Street's second acquired company in the past six weeks, it also proffers test kits and an automated testing system.